Panacea Life Sciences Stock Analysis
| PLSH Stock | USD 0.04 0.01 18.37% |
Panacea Life Sciences has over 3.26 Million in debt which may indicate that it relies heavily on debt financing. With a high degree of financial leverage come high-interest payments, which usually reduce Panacea Life's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Panacea Life's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Panacea Life's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the OTC Stock is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Panacea OTC Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Panacea Life's stakeholders.
For many companies, including Panacea Life, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Panacea Life Sciences, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Panacea Life's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Panacea Life's debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Panacea Life is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Panacea Life to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Panacea Life is said to be less leveraged. If creditors hold a majority of Panacea Life's assets, the OTC Stock is said to be highly leveraged.
Panacea Life Sciences is overvalued with Real Value of 0.0384 and Hype Value of 0.04. The main objective of Panacea Life otc analysis is to determine its intrinsic value, which is an estimate of what Panacea Life Sciences is worth, separate from its market price. There are two main types of Panacea Life's stock analysis: fundamental analysis and technical analysis.
The Panacea Life otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Panacea Life's ongoing operational relationships across important fundamental and technical indicators.
Panacea |
Panacea OTC Stock Analysis Notes
About 63.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.46. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Panacea Life Sciences recorded a loss per share of 0.46. The entity last dividend was issued on the 11th of March 2019. The firm had 1:28 split on the 28th of October 2021. Panacea Life Sciences Holdings, Inc., a seed to sale cannabinoid and nutraceutical manufacturer and research company, develops and produces natural pharmaceutical alternatives for consumers and pets. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado. Panacea Life operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 29 people.The quote for Panacea Life Sciences is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Panacea Life Sciences contact Leslie Buttorff at 800 985 0515 or learn more at https://www.panacealife.com.Panacea Life Sciences Investment Alerts
| Panacea Life had very high historical volatility over the last 90 days | |
| Panacea Life has some characteristics of a very speculative penny stock | |
| Panacea Life has high likelihood to experience some financial distress in the next 2 years | |
| Panacea Life Sciences currently holds 3.26 M in liabilities with Debt to Equity (D/E) ratio of 7.61, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Panacea Life Sciences has a current ratio of 0.61, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Panacea Life until it has trouble settling it off, either with new capital or with free cash flow. So, Panacea Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Panacea Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Panacea to invest in growth at high rates of return. When we think about Panacea Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.06 M. Net Loss for the year was (4.78 M) with loss before overhead, payroll, taxes, and interest of (4.42 M). | |
| Panacea Life Sciences currently holds about 2.6 M in cash with (3.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 63.0% of Panacea Life outstanding shares are owned by corporate insiders |
Panacea Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.33 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Panacea Life's market, we take the total number of its shares issued and multiply it by Panacea Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 7th of February, Panacea Life holds the Risk Adjusted Performance of 0.0099, coefficient of variation of 167066.72, and Semi Deviation of 10.0. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Panacea Life, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We are able to interpolate and collect nineteen technical drivers for Panacea Life Sciences, which can be compared to its competitors.Panacea Life Sciences Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two.
Panacea Life Outstanding Bonds
Panacea Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Panacea Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Panacea bonds can be classified according to their maturity, which is the date when Panacea Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Panacea Life Predictive Daily Indicators
Panacea Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Panacea Life otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 0.82 | |||
| Day Median Price | 0.04 | |||
| Day Typical Price | 0.04 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0.01) |
Panacea Life Forecast Models
Panacea Life's time-series forecasting models are one of many Panacea Life's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Panacea Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Panacea Life Sciences Debt to Cash Allocation
Panacea Life Sciences currently holds 3.26 M in liabilities with Debt to Equity (D/E) ratio of 7.61, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Panacea Life Sciences has a current ratio of 0.61, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Panacea Life until it has trouble settling it off, either with new capital or with free cash flow. So, Panacea Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Panacea Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Panacea to invest in growth at high rates of return. When we think about Panacea Life's use of debt, we should always consider it together with cash and equity.Panacea Life Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Panacea Life's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Panacea Life, which in turn will lower the firm's financial flexibility.Panacea Life Corporate Bonds Issued
Most Panacea bonds can be classified according to their maturity, which is the date when Panacea Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Panacea OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Panacea Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Panacea shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Panacea Life. By using and applying Panacea OTC Stock analysis, traders can create a robust methodology for identifying Panacea entry and exit points for their positions.
Panacea Life Sciences Holdings, Inc., a seed to sale cannabinoid and nutraceutical manufacturer and research company, develops and produces natural pharmaceutical alternatives for consumers and pets. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado. Panacea Life operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 29 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Panacea Life to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Complementary Tools for Panacea OTC Stock analysis
When running Panacea Life's price analysis, check to measure Panacea Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Panacea Life is operating at the current time. Most of Panacea Life's value examination focuses on studying past and present price action to predict the probability of Panacea Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Panacea Life's price. Additionally, you may evaluate how the addition of Panacea Life to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |